Neuroloxía

2020

1. 5-2-1 Criteria: A Simple Screening Tool for Identifying Advanced PD Patients Who Need an Optimization of Parkinson's Treatment

   Parkinson's Disease, Vol. 2020

2. A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis

   Multiple Sclerosis Journal, Vol. 26, Núm. 9, pp. 1074-1082

3. Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration

   The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 75, Núm. 3, pp. 416-424

4. Alopecia in Meralgia Paresthetica

   Actas Dermo-Sifiliograficas, Vol. 111, Núm. 1, pp. 69

5. Amendment on the article “Missing outcome data management in acute stroke trials testing iv thrombolytics: Is there risk of bias?”

   European Stroke Journal

6. Angiotensin AT1and AT2receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia

   Journal of Neuroinflammation, Vol. 17, Núm. 1

7. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

   Brain, Behavior, and Immunity, Vol. 87, pp. 256-271

8. Antihyperthermic treatment decreases perihematomal hypodensity

   Neurology, Vol. 94, Núm. 16, pp. E1738-E1748

9. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

   Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

10. Author response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine

    Neurology

11. Blood biomarkers predictive of epilepsy after an acute stroke event

    Epilepsia, Vol. 61, Núm. 10, pp. 2244-2253

12. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

    The Lancet Neurology

13. Cerebellar Cognitive Affective Syndrome in Costa da Morte Ataxia (SCA36)

    Cerebellum, Vol. 19, Núm. 4, pp. 501-509

14. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36

    Neuron, Vol. 107, Núm. 2, pp. 292-305.e6

15. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

    Frontiers in Neurology, Vol. 11

16. Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome

    Revista de Neurologia, Vol. 71, Núm. 6, pp. 221-224

17. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset

    Neurology, Vol. 94, Núm. 11, pp. e1171-e1180

18. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

19. Congenital left ventricular outpouching and patent foramen ovale: A potentially emboligenic combination

    Neurologia

20. Consensus statement for the management of generalized tonic-clonic seizures in Spain

    Acta Neurologica Scandinavica, Vol. 141, Núm. 1, pp. 22-32